Complete denial imo most likely due to NO partnership.
No, the professional world's inattention to Anavex, whether in medicine or investing, is "denied" by the fact that Anavex's approach to treating CNS diseases is entirely outside the professional world's knowledge base of what's real. Some obscure sigma-1 receptor protein ligand can fix CNS diseases? Get real. Nothing about it in any medical textbook; just tau and beta-amyloid protein agglomerations. The professional smart people know better.